Mark lives symptom-free with MDS, but it's still "like an albatross"
Person's Name:
Mark
Mark had no symptoms common to bone marrow failure patients.
Not one.
Bone Marrow Disease(s):
Content source:
treatment
2019 update! My Son, the Athlete and Survivor - Sam Thrives Years after Transplant
Person's Name:
Samuel Meidinger
Bone Marrow Disease(s):
Content source:
What Happens in a Clinical Trial? How do I know if it's the right option for me?
Why would I choose a clinical trial? What kind of additional care would I receive? How do I know if I qualify?
Christina Cline, RN, BSN, CCRC, explains both patient and nurse navigator roles in this recent recording.
Surprised by diagnosis, Mark learns to live with low-risk Myelodysplastic Syndrome
Mark had no symptoms prior to diagnosis. Even more surprising was the "watch and wait" treatment plan! Listen to this recently recorded episode where Mark describes living as an MDS survivor now.
Alison R. Walker, MD
Walker, Alison
H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida
Dr. Walker received her MD from University of Rochester School of Medicine and Dentistry. She completed an Internal Medicine Residency and a Hematology/Oncology Fellowship at the University of Rochester, New York. She joins us from The Ohio State University, where she served as a Professor in the Department of Internal Medicine, Division of Hematology. Dr. Walker’s clinical interests are in the care of patients with myeloid malignancies, specifically
Online Profile:
Jeffrey J. Pu, MD, PhD
Pu, Jeffrey J.
Associate Professor, Medicine; Clinical and Translational Oncology Program; Chief of Leukemia and BMF Diseases Section
University of Arizona Cancer Center in Tuscon,
Bhumika Patel, MD
Patel, Bhumika
Prisma Health Cancer Institute - Eastside
Mrinal Patniak, MD, MBBS
Patniak, Mrinal
Associate Professor of Medicine
Mayo Clinic Minnesota
Online Profile:
David Araten, MD
Araten, David
Assistant Professor of Medicine
NYU School of Medicine
Dr. David Araten is an assistant professor in the Division of Hematology at the NYU School of Medicine in New York City. Prior to holding this position, he worked as an assistant professor and instructor in hematology at Memorial Sloan-Kettering Cancer Center, also in New York City. His residency was in internal medicine at Columbia-Presbyterian Medical Center and received his medical degree from Harvard Medical School in Boston. Dr. Araten’s research has focused largely on PNH and he has published in a wide variety of peer reviewed journals on this topic.
Online Profile:
Gregory Abel, MD, MPH
Abel, Gregory
Dana-Farber Cancer Institute
Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.
Online Profile: